RegMed Daily, Closing Bell, 4/12/12, stocks are higher and getting closer to psychotically significant levels, as XIX dropped to 18, hoping a few stocks rise to break shorts grip on pricing
EOD Commentary: RegMed stocks rallied for a 2nd session Thursday, recouping from the recent selloff … boosted by stronger <by some companies> prospects for better movement to the upside . .. the key will be to break the – strangle hold – shorts – have in this universe!!
Closing Bell: The NASDAQ closed UP +39.09 (+1.3%) to 3,055.55. The Dow closed UP +$181.19 <+1.41%) to 12,989.58.
Who’s up … at the close:
- Aastrom (ASTM) +$0.11 <5.29> to $2.29;
- BioMimetic (BMTI) +$0.02 <+0.77%> to $2.61;
- Cryo-Cell (OTC BB: CCEL) +$0.02 <+0.83%> to $2.61;
- Cytomedix (OTC BB: CMXI) +$0.08 <+5.71%> to $1.48;
- Cytori (CYTX) +$0.06 <+2.54%> TO $2.42;
- Geron (Ger) +$0.03 <+1.96%> to $1.56;
- ImmunoCellular (OTC BB: IMUC) +$0.01 <+0.36%> to $2.76;
- NeoStem (Amex: NBS) +$0.009 <+2.84%> to $0.33;
- Opexa (OPXA) +$0.06 <+10.91%> to $1.57;
- Pluristem (PSTI) +$0.01 <+0.46%> to $2.17;
- Tengion (TNGN) +$0.02 <+4.189%> to $0.55.
![50194787B[1]](http://www.scimitarequity.com/blog/wp-content/uploads/50194787B1-e1307466532356.jpg)






